Life-Threatening Hypercalcemia During Prodrome of Pneumocystis jiroveci Pneumonia in an Immunocompetent Infant. (29th April 2017)

• Record Type: Journal Article
• Authors: VanSickle, Judith Sebestyen; Srivastava, Tarak; Alon, Uri S.
• Is Part Of: Global pediatric health. Volume 4(2017)
• Publication Date: 2017-04-29
• Subjects: hypercalcemia -- Pneumocystis jiroveci pneumonia -- calcitriol -- zoledronic acid; Pediatrics -- Periodicals; Children -- Health and hygiene -- Periodicals; 618.92
• DOI: 10.1177/2333794X17705955
• Languages: English
• ISSNs: 2333-794X

Abstract

Severe hypercalcemia in infants is usually attributed to genetic etiologies and less commonly to acquired ones. An 8-week-old girl presented with failure to thrive, mild respiratory distress, and life-threatening hypercalcemia (23.5 mg/dL). Serum 1, 25(OH)2 -vitamin D (1, 25(OH)2 -D) level was elevated and parathyroid hormone undetectable. Evaluation for genetic mutations and malignant etiologies of hypercalcemia was negative. Treatment with intravenous hydration, loop diuretic, and calcitonin failed to correct the hypercalcemia, which was subsequently controlled with bisphosphonate therapy. Due to progressive respiratory deterioration, a bronchopulmonary lavage was done on day 17 of her hospitalization disclosing Pneumocystis jiroveci infection. The subsequent immunological investigation showed no abnormalities. She was treated with trimethoprim/sulfamethoxazole resulting in gradual clearing of her lungs and normalization of serum 1, 25(OH)2 -D level. A year later, she remains healthy with normal biochemical parameters of mineral metabolism. We conclude that in a child with hypercalcemia with suppressed parathyroid hormone and elevated 1, 25(OH)2 -D, once the genetic etiology for elevated 1, 25(OH)2 -D and malignancy are ruled out, one should investigate closely for a chronic granulomatous disease. Among the latter Pneumocystis jiroveci pneumonia infection should be considered even in an immunocompetent child.